Preise & Rabatte einsehen
Geschenke sichern
Angebote anfragen & online annehmen
Astrocytoma
| Name | Preis | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — APC - 50 µg | Anmelden | Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — APC - 50 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — APC - 200 µg | Anmelden | Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — APC - 200 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — Biotin - 100 µg | Anmelden | Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — Biotin - 100 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — Biotin - 200 µg | Anmelden | Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — Biotin - 200 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — FITC - 50 µg | Anmelden | Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — FITC - 50 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — FITC - 100 µg | Anmelden | Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — FITC - 100 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — FITC - 200 µg | Anmelden | Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — FITC - 200 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — PE - 50 µg | Anmelden | Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — PE - 50 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — PE - 100 µg | Anmelden | Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — PE - 100 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — PE - 200 µg | Anmelden | Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — PE - 200 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — Purified - 200 µg | Anmelden | Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — Purified - 200 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — Purified (PhenoCyler-Fusion (CODEX)® Ready) - 50 µg | Anmelden | Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — Purified (PhenoCyler-Fusion (CODEX)® Ready) - 50 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human Tuberous Sclerosis Complex 1 (CT) (TSC1) - 0.1 mg | Anmelden | Anti-Human Tuberous Sclerosis Complex 1 (CT) (TSC1) - 0.1 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human Tuberous Sclerosis Complex 2 (CT) (TSC2) - 0.1 mg | Anmelden | Anti-Human Tuberous Sclerosis Complex 2 (CT) (TSC2) - 0.1 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human Tuberous Sclerosis Complex 2 (CT) (TSC2) - 20 µg | Anmelden | Anti-Human Tuberous Sclerosis Complex 2 (CT) (TSC2) - 20 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human Tuberous Sclerosis Complex 1 (CT) (TSC1) - 20 µg | Anmelden | Anti-Human Tuberous Sclerosis Complex 1 (CT) (TSC1) - 20 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human EGFR (Necitumumab) - 1.0 mg | Anmelden | Anti-Human EGFR (Necitumumab) - 1.0 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human EGFR (Necitumumab) - 100 mg | Anmelden | Anti-Human EGFR (Necitumumab) - 100 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human EGFR (Necitumumab) - 25 mg | Anmelden | Anti-Human EGFR (Necitumumab) - 25 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human EGFR (Necitumumab) - 5.0 mg | Anmelden | Anti-Human EGFR (Necitumumab) - 5.0 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human EGFR (Necitumumab) - 50 mg | Anmelden | Anti-Human EGFR (Necitumumab) - 50 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human EGFR (Necitumumab) – Fc Muted™ - 500 µg | Anmelden | Anti-Human EGFR (Necitumumab) – Fc Muted™ - 500 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human EGFR (Panitumumab) - 100 mg | Anmelden | Anti-Human EGFR (Panitumumab) - 100 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human EGFR (Panitumumab) - 1.0 mg | Anmelden | Anti-Human EGFR (Panitumumab) - 1.0 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human EGFR (Panitumumab) - 25 mg | Anmelden | Anti-Human EGFR (Panitumumab) - 25 mg | ||||||||||||||||
|
||||||||||||||||||
